Mucosal immunology, microbiology and HIV susceptibility
Thursday, February 4, 2021
•
OA19
•
3:00 PM
>
4:00 PM
•
Mucosal immunology, microbiology and HIV susceptibility
•
Live channel 2
This session explores mucosal immunology, bacteriology, HIV susceptibility and the impact of various interventions such as sex, BV treatment and hormonal contraception.
3:00 PM
•
OA19.01
•
Impact of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomized placebo-controlled trial
See abstract
3:08 PM
•
OA19.02
•
Construction of a comprehensive bacterial genome catalogue for the female genital tract identifies hundreds of new species
See abstract
3:16 PM
•
OA19.03
•
Transcriptional analysis of cervical cell populations reveals inflammatory signatures and differential epithelial keratinization associated with Depo-Provera use
See abstract
3:24 PM
•
OA19.04LB
•
Silk fibroin as a mucosal delivery vehicle for Griffithsin and antiviral compounds: effective protection of macaques and high acceptance among user groups
See abstract
3:32 PM
•
OA19.05LB
•
Pharmacokinetic and pharmacodynamic study of tenofovir and tenofovir alafenamide for PrEP in foreskin tissue
See abstract
3:40 PM
•
OA19.06
•
Live Q&A
See abstract
|